VaccinesOur Vaccines business has the broadest portfolio of any company, with vaccines for people of all ages. We deliver over two million vaccine doses per day to people across over 160 countries.
Our Vaccines business has a portfolio of 41 paediatric, adolescent, adult, other people and travel vaccines that offer protection against 22 different diseases. We have a pipeline of 14 candidate vaccines in early, mid and late stage development against a range of diseases. Our pipeline of potential new vaccines covers many of the diseases still having a serious impact around the world, including malaria, HIV, TB and Ebola. In 2016, the business contributed £4.6 billion (16%) to the overall turnover of the Group.